Cholesterol & Lipid
Sort by:
Houston Methodist DeBakey Heart and Vascular Center
CAC Score for Aspirin Allocation
FEATURING
Miguel Cainzos-Achirica
- 391 views
- January 25, 2022
- 2
Cardiovascular Disease Management: A Case-Based Approach 2018
Can Heart Disease Be Abolished? The PCSK9 Revolution
FEATURING
Christie Ballantyne
- 395 views
- December 21, 2018
- 2
Canadian Collaborative Research Network
Approaching a Decade of PCSK9 Inhibition: Effects on CV Mortality
FEATURING
Milan Gupta
- 398 views
- July 26, 2023
- 2
Cedars Sinai
Repurposing Colchicine for Atherosclerosis
FEATURING
Jean-Claude Tardif
- 402 views
- February 4, 2022
- 2
The Texas Heart Institute
Insights into Triglyceride Reduction: What Do the Treatment Guidelines Tell Us and Why?
FEATURING
Salim Virani
- 410 views
- April 22, 2021
- 2
American College of Cardiology
ESC Congress 2022: SECURE, ENTRIGUE, TIME, and REDUCE-IT Trials
- 174 views
- September 20, 2022
- 1
Houston Methodist DeBakey Heart and Vascular Center
Aspirin: Not a "Wonder Drug" Anymore?
FEATURING
Miguel Cainzos-Achirica
- 433 views
- January 25, 2022
- 2
Houston Methodist DeBakey Heart and Vascular Center
Atherosclerosis Imaging: Major Role in Risk Assessment and Management
FEATURING
Ron Blankstein
- 178 views
- October 18, 2021
- 1
Georgia Heart Institute
In Vivo Imaging of the Immune System for Health & Disease Assessment
FEATURING
Zahi Fayad
- 474 views
- May 9, 2023
- 2
National Lipid Association
Pregnancy, Lipid Effects, and ASCVD Risk Management
FEATURING
Rachel M. Bond
- 196 views
- October 11, 2023
- 1
Penn Medicine Heart and Vascular Center
Who Is Appropriate for PCSK-9 Inhibitors, Including Inclisiran?
FEATURING
Archna Bajaj
- 541 views
- November 21, 2023
- 2
Houston Methodist DeBakey Heart and Vascular Center
How to Choose from Established and Emerging Lipid Lowering Therapies
FEATURING
Christie Ballantyne
- 553 views
- November 15, 2022
- 2
4th Annual Cardiovascular Conference: Advances in Cardiovascular Disease - from Prevention to Intervention
Updates in Antiplatelet & Antithrombotic Treatments for ASCVD: Should You Consider Ticagrelor and Prasugrel in Patients With ACS? When to Use Triple Therapy and How Helpful Is It in Reducing Bleeding?
FEATURING
Sripal Bangalore
- 201 views
- April 22, 2021
- 1
AAD 2024
AAD 2024 Insights: Side Effects of Systemic Glucocorticoids (GI, Endocrine, Lipids)
FEATURING
Victoria Werth
- 578 views
- March 20, 2024
- 2
Cardiovascular Disease Management: A Case-Based Approach 2018
PCI Post ORBITA: Does This Really Change Our Treatment of Chronic Stable Angina?
FEATURING
Kirk Garratt
- 858 views
- December 21, 2018
- 2